Safety Perceptions of Health Care Leaders in 2 Canadian Academic Acute Care Centers.

J Patient Saf

From the Departments of *Anesthesiology and Perioperative Medicine, and †Surgery, Queen's University, Kingston, Ontario, Canada; ‡Department of Anthropology, Ball State University, Muncie, IN; and §School of Nursing, Queen's University, Kingston, Ontario, Canada.

Published: June 2017

Objectives: An estimated 7.4% of patients admitted to acute care facilities in Canada experience injury or death due to health care mishaps, and 38% of these events are deemed preventable. Commitment of executive leaders to a culture of safety is important for the reduction of risk to Canadian patients. The purpose of this study was to examine the safety climate from a leader's perspective in 2 Canadian acute care settings, with attention paid to high reliability organization (HRO) principles.

Methods: The Patient Safety Culture in Healthcare Organizations questionnaire was administered to leaders in 2 acute care hospitals in Ontario between June and January 2009. The primary outcome measures were senior leadership support for safety and supervisory leadership support for safety. Misalignment between the safety climate and HRO principles was defined as greater than 10% of respondents reporting problematic or neutral leadership support for safety.

Results: Of the 142 respondents (67% response rate), both medical/nursing leaders and tertiary care clinical leaders were significantly more likely than board/administrative leaders to report problematic/neutral responses. Overall, executive leadership perceptions of the safety climate were not aligned with HRO principles.

Conclusions: The significant differences in response between board/administrative leaders and those involved in frontline patient care suggest that a weak safety culture exists in these 2 health care organizations. The cultivation of a stronger organizational safety culture, in alignment with HRO principles, could lead to lower rates of preventable mishaps and support risk identification and mitigation in perioperative settings.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PTS.0000000000000112DOI Listing

Publication Analysis

Top Keywords

acute care
16
health care
12
safety climate
12
safety culture
12
leadership support
12
safety
10
care
9
support safety
8
hro principles
8
board/administrative leaders
8

Similar Publications

Demystifying Citrate Anticoagulation: Function, Monitoring, and Practical Insights for Nursing Practice.

Nephrol Nurs J

January 2025

Clinical Applications and Product Innovation Staff Engineer, Fresenius Medical Care, Lawrence, MA.

Citrate anticoagulation offers a targeted and effective method for preventing clotting in extracorporeal blood circuits during dialysis. This article reviews the mechanisms, benefits, risks, and best practices associated with citrate anticoagulation, emphasizing its growing role within critical care and dialysis.

View Article and Find Full Text PDF

Patients with acute kidney injury often require dialysis (AKI-D) in the outpatient setting following hospitalization. Management of the patient with AKI-D should focus on preventing further insult to the damaged kidney and recovery of kidney function. Clinical attention should include continuity of care, education, infection control, medication management, and fluid management.

View Article and Find Full Text PDF

Prolonged incubation time unwarranted for acute periprosthetic joint infections.

J Clin Microbiol

January 2025

Department of Medical Microbiology, Infectious Diseases and Infection Prevention, Maastricht University Medical Centre, Maastricht, the Netherlands.

Unlabelled: Current laboratory protocols for periprosthetic joint infections (PJIs) involve a standard 10- to 14-day incubation period. However, recent evidence indicates considerable variability in the time to diagnosis (TTD) between acute and chronic PJIs. TTD is also influenced by the employed culture media and sample types.

View Article and Find Full Text PDF

PurposeChimeric antigen receptor (CAR) T-cell CD19 therapy has changed the treatment paradigm for patients with relapsed/refractory B-cell acute lymphoblastic leukemia. It is frequently associated with potentially severe toxicities: cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), and admission to PICU is often required. Some biomarkers seem to correlate with CRS severity.

View Article and Find Full Text PDF

Background: Leukemia may form at any age, from newborns to the elderly, and accounts for considerable mortality worldwide.

Objectives: Nerolidol (NRD) is isolated from the aromatic florae oils and was found to have anticancer activities. However, the role of NRD in antiproliferative and apoptosis actions in acute lymphoblastic leukemia (ALL) is unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!